Document is current
Any future updates will be listed below
-
Authors
Wang, Deqiang
Wang, Ning
Li, Xiaoqin
Chen, Xiaofeng
Shen, Bo
Zhu, Dongqin
Zhu, Liuqing
Xu, Yaping
Yu, Yangyang
Shu, Yongqian https://orcid.org/0000-0003-2103-0877
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81502130)
National Natural Science Foundation of China (81672896)
National Natural Science Foundation of China (81972822)
- License Information
-
More Information
Article History
Received: 16 September 2020
Accepted: 16 February 2021
First Online: 9 March 2021
Declarations
:
: Dongqin Zhu and Liuqing Zhu are the employees of Geneseeq Technology Inc. Yaping Xu is the employee of Geneplus-Beijing Institute. Yangyang Yu is the employee of 3D Medicines Inc. The remaining authors declare that they have no competing interests.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Written informed consent was obtained from all patients and the research protocol was approved by the Ethics Committee in the AHJU.
Free to read: This content has been made available to all.
